neurovascular

News

ARPA-H has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous remote endovascular robotics.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.